Hsinchu, Taiwan — August 9, 2021 — Visgeneer Group celebrates the addition of a new member to its eBmonitor® range of blood monitors: the all-new eBuricacid Blood Uric Acid Monitoring System. eBuricacid is equipped with the industry's most advanced specifications - including fastest result of mere 15 seconds and least blood sample of 0.5uL.

For more information on our eBuricacid Blood Uric Acid Monitoring System, please click here.

About Visgeneer Group

Based in Hsinchu, Taiwan, Visgeneer Group is a global innovator for health solutions encompassing blood diagnostics, EU Patent skincare, zeaxanthin and cancer gene testing. Since our inception in 2005, we have produced award-winning products and industry firsts and continue to work relentlessly to empower individuals, regardless of health conditions they may have, to live life to their fullest under our vision "Envisioning the world anew. Engineering for Generations to come." Visgeneer is listed in Taiwan with stock ticker 4197. For more information on Visgeneer Group, please visit www.visgeneer.com/en.